REGENXBIO Inc. 13D and 13G filings for PREVAIL THERAPEUTICS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 4:19 pm Sale |
2020-12-31 | 13G | PREVAIL THERAPEUTICS INC PRVL |
REGENXBIO Inc. RGNX |
0 0.000% |
-2,030,000 (Position Closed) |
Filing |